Tried to warn you guys. getting close to that 20% pull back as previously stated. Doesn't mean there is anything wrong with the company or product, just the price. I've learned over the years that the charts do tell you something. News is generally slow in the bio tech world. You always seem to have time to sell and buy back in to grab some more free shares.
While you were correct in your trading analysis of AMPE stock movement, most of the other people on this board that are regular participants are not really trading this stock. Most are INVESTORS. Your participation is very welcome but please reference the word "TRADING" somewhere in your posts. I too expected a pullback after a 50% move in less than 1 month
what is the basis of your short thesis? Fundamentals? or technical? It must be on the stretched bands, because the company can not be precisely valued given that its a developmental pharm. With Ampion approval the valuation will make the current market cap look like pocket change.